New drugs for the treatment of metastatic colorectal cancer

doi:10.4251/wjgo.v13.i11.1551

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4653)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

257

WORD

HTML

2540

Figures (1-1)

238

Tables (1-1)

287

Sum=3406

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

426

Download

821

Sum=1247

Nov 15, 2021 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1551-1560
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1551

Open in New Tab Full Size Figure Download Figure

Figure 1 Main resistance mechanisms in targeted treatment for metastatic colorectal cancer. EGFR: Epidermal growth factor receptor; VEGF: Vascular endothelial growth factor; TGF-β: Transforming growth factor-β; IL1: Interleukin 1.

Citation: Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560
URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1551.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1551